Form D Raw Data - Electronic Filing Depository

EFDID: 38072EFD: Raw Data

Issuer: FLUOROPHARMA MEDICAL, INC. (0001402785) - D

Accession: 0001140361-11-030822 () (EDGAR Files) (Form D)

Edgar Posted: Jun. 1, 2011
EFD Posted: Aug. 7, 2014

- < edgarSubmission >

< schemaVersion > X0704 </ schemaVersion >

< submissionType > D </ submissionType >

< testOrLive > LIVE </ testOrLive >

- < primaryIssuer >

< cik > 0001402785 </ cik >

< entityName > FLUOROPHARMA MEDICAL, INC. </ entityName >

- < issuerAddress >

< street1 > 500 Boylston Street, Suite 1600 </ street1 >

< city > Boston </ city >

< stateOrCountry > MA </ stateOrCountry >

< stateOrCountryDescription > MASSACHUSETTS </ stateOrCountryDescription >

< zipCode > 02116 </ zipCode >

</ issuerAddress >

< issuerPhoneNumber > 6174822333 </ issuerPhoneNumber >

< jurisdictionOfInc > NEVADA </ jurisdictionOfInc >

- < issuerPreviousNameList >

< value > None </ value >

</ issuerPreviousNameList >

- < edgarPreviousNameList >

< previousName > Commercial E-Waste Management Inc </ previousName >

</ edgarPreviousNameList >

< entityType > Corporation </ entityType >

- < yearOfInc >

< withinFiveYears > true </ withinFiveYears >

< value > 2007 </ value >

</ yearOfInc >

</ primaryIssuer >

- < relatedPersonsList >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Johan (Thijs) </ firstName >

< middleName > M. </ middleName >

< lastName > Spoor </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 500 Boylston Street, Suite 1600 </ street1 >

< city > Boston </ city >

< stateOrCountry > MA </ stateOrCountry >

< stateOrCountryDescription > MASSACHUSETTS </ stateOrCountryDescription >

< zipCode > 02116 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Executive Officer </ relationship >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > David </ firstName >

< middleName > R. </ middleName >

< lastName > Elmaleh </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 500 Boylston Street, Suite 1600 </ street1 >

< city > Boston </ city >

< stateOrCountry > MA </ stateOrCountry >

< stateOrCountryDescription > MASSACHUSETTS </ stateOrCountryDescription >

< zipCode > 02116 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Executive Officer </ relationship >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Walter </ firstName >

< lastName > Witshkin </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 500 Boylston Street, Suite 1600 </ street1 >

< city > Boston </ city >

< stateOrCountry > MA </ stateOrCountry >

< stateOrCountryDescription > MASSACHUSETTS </ stateOrCountryDescription >

< zipCode > 02116 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Peter </ firstName >

< middleName > S. </ middleName >

< lastName > Conti </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 500 Boylston Street, Suite 1600 </ street1 >

< city > Boston </ city >

< stateOrCountry > MA </ stateOrCountry >

< stateOrCountryDescription > MASSACHUSETTS </ stateOrCountryDescription >

< zipCode > 02116 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

</ relatedPersonInfo >

</ relatedPersonsList >

- < offeringData >

- < industryGroup >

< industryGroupType > Pharmaceuticals </ industryGroupType >

</ industryGroup >

- < issuerSize >

< revenueRange > No Revenues </ revenueRange >

</ issuerSize >

- < federalExemptionsExclusions >

< item > 06 </ item >

</ federalExemptionsExclusions >

- < typeOfFiling >

- < newOrAmendment >

< isAmendment > false </ isAmendment >

</ newOrAmendment >

- < dateOfFirstSale >

< value > 2011-05-16 </ value >

</ dateOfFirstSale >

</ typeOfFiling >

- < durationOfOffering >

< moreThanOneYear > false </ moreThanOneYear >

</ durationOfOffering >

- < typesOfSecuritiesOffered >

< isEquityType > true </ isEquityType >

< isOptionToAcquireType > true </ isOptionToAcquireType >

</ typesOfSecuritiesOffered >

- < businessCombinationTransaction >

< isBusinessCombinationTransaction > true </ isBusinessCombinationTransaction >

< clarificationOfResponse > The issuer completed a reverse merger transaction on May 16, 2011. </ clarificationOfResponse >

</ businessCombinationTransaction >

< minimumInvestmentAccepted > 0 </ minimumInvestmentAccepted >

- < salesCompensationList >

- < recipient >

< recipientName > Burnham Hill Partners, LLC </ recipientName >

< recipientCRDNumber > 148000 </ recipientCRDNumber >

< associatedBDName > None </ associatedBDName >

< associatedBDCRDNumber > None </ associatedBDCRDNumber >

- < recipientAddress >

< street1 > 590 Madison Avenue, 5th Floor </ street1 >

< city > New York </ city >

< stateOrCountry > NY </ stateOrCountry >

< stateOrCountryDescription > NEW YORK </ stateOrCountryDescription >

< zipCode > 10022 </ zipCode >

</ recipientAddress >

- < statesOfSolicitationList >

< state > CA </ state >

< description > CALIFORNIA </ description >

< state > NY </ state >

< description > NEW YORK </ description >

< state > TX </ state >

< description > TEXAS </ description >

</ statesOfSolicitationList >

< foreignSolicitation > false </ foreignSolicitation >

</ recipient >

- < recipient >

< recipientName > Monarch Capital Group, LLC </ recipientName >

< recipientCRDNumber > 47815 </ recipientCRDNumber >

< associatedBDName > None </ associatedBDName >

< associatedBDCRDNumber > None </ associatedBDCRDNumber >

- < recipientAddress >

< street1 > 500 Fifth Avenue, Suite 2240 </ street1 >

< city > New York </ city >

< stateOrCountry > NY </ stateOrCountry >

< stateOrCountryDescription > NEW YORK </ stateOrCountryDescription >

< zipCode > 10110 </ zipCode >

</ recipientAddress >

- < statesOfSolicitationList >

< state > CT </ state >

< description > CONNECTICUT </ description >

< state > MN </ state >

< description > MINNESOTA </ description >

< state > NY </ state >

< description > NEW YORK </ description >

</ statesOfSolicitationList >

< foreignSolicitation > false </ foreignSolicitation >

</ recipient >

</ salesCompensationList >

- < offeringSalesAmounts >

< totalOfferingAmount > 6000000 </ totalOfferingAmount >

< totalAmountSold > 3667442 </ totalAmountSold >

< totalRemaining > 2332558 </ totalRemaining >

</ offeringSalesAmounts >

- < investors >

< hasNonAccreditedInvestors > false </ hasNonAccreditedInvestors >

< totalNumberAlreadyInvested > 31 </ totalNumberAlreadyInvested >

</ investors >

- < salesCommissionsFindersFees >

- < salesCommissions >

< dollarAmount > 227696 </ dollarAmount >

</ salesCommissions >

- < findersFees >

< dollarAmount > 0 </ dollarAmount >

</ findersFees >

</ salesCommissionsFindersFees >

- < useOfProceeds >

- < grossProceedsUsed >

< dollarAmount > 0 </ dollarAmount >

</ grossProceedsUsed >

</ useOfProceeds >

- < signatureBlock >

< authorizedRepresentative > false </ authorizedRepresentative >

- < signature >

< issuerName > FLUOROPHARMA MEDICAL, INC. </ issuerName >

< signatureName > /s/ Johan M. (Thijs) Spoor </ signatureName >

< nameOfSigner > Johan M. (Thijs) Spoor </ nameOfSigner >

< signatureTitle > Chief Executive Officer </ signatureTitle >

< signatureDate > 2011-06-01 </ signatureDate >

</ signature >

</ signatureBlock >

</ offeringData >

</ edgarSubmission >